Table 1.
Basic, clinical and biochemical characteristics in examined groups
| CLINICAL GROUP N=100 | ||||
| Mean values | Osteoporosis | Osteopenia | Control group | p values |
| Number (%) | 40 (33%) | 60 (50%) | 20 (17%) | P<0.01 |
| Age (year) | 61.44±7.25 | 56.62±6.32 | 53.18±6.02 | P>0.05 |
| BMD-total (g/cm2) | 1.012±0.102* | 1.087±0.068 | 1.209±0.115 | P=0.041 |
| BMDL2-L4 (g/cm2) | 0.803±0.121* | 0.897±0.083 | 1.112±0.128 | P=0.023 |
| BMD-hip (g/cm2) | 0.623±0.086* | 0.706±0.062 | 0.877±0.064 | P=0.037 |
| Adiponectin (pg/mL) | 856.87±453.43** | 1287.32±405.21 | 1785.76±444.02 | P=0.008 |
| Normoadiponectinemia | 8 (20%) | 21 (35%) | 14 (70%) | P<0.001 |
| Hypoadiponectinemia | 32 (80%) | 39 (65%) | 6 (30%) | P<0.001 |
**
The differences between clinical subgroups are significant to the 0.01 level
*
0.05 level.
BMD-Bone mineral density, BMDL2-L4-Lumbar spine BMD, BMD-hip-Femoral neck BMD.